Regulatory approval received for acquisition of Kemwell Indian operations

Published: 3-Jan-2017
Manufacturing Finance

Recipharm expands operations in India


Further to the announcement on 18 April 2016 that Recipharm would acquire the pharma division of Kemwell’s Indian operation, the Indian Foreign Investment Promotion Board has now granted approval for this transaction to take place.

Closing is expected to occur at the beginning of 2017 and comprises the acquisition of Kemwell’s pharmaceutical manufacturing and development operations located in Bengaluru known as Recipharm Pharmaservices Private Ltd.

  • Companies:
  • Recipharm
  • Kemwell Pvt
See more

You may also like

Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

Read more
The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting

Trending Articles

  1. Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. Vetter strengthens senior management team for growth Three new managing directors to support global sustainable development

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting
Manufacturing

ReciBioPharm partners with Hongene Biotech to provide sgRNA manufacturing capabilities

ReciBioPharm will now offer sgRNA manufacturing capabilities on top of its current mRNA, LNP and fill-finish services
Training & Education

Women in pharma: the battle against mansplaining continues

Prejudice in the workplace is an affliction suffered by many, but how can the industry be free from this nasty virus?
Manufacturing

Recipharm, Medspray and Resyca enter into license agreement to develop nasally-delivered soft mist drug products

Recipharm, Medspray and Resyca have entered an exclusive collaboration and licensing agreement to develop soft mist nasal delivery devices for single and combination drug products.
Manufacturing

Overcoming bio/pharmaceutical production hurdles: an industry insider perspective

From F-gas regulation to finance and from biologics to personalised medicines, the global drug production environment faces a number of challenges that could potentially stifle innovation and profitability. Dr Kevin Robinson (KSR) recently spoke to key players in the supplier and outsourcing community to better understand what services and solutions are available to keep the pipeline flowing
Manufacturing

Recipharm’s analytical lab brings testing capabilities to global markets

Fully cGMP/cGLP compliant, the 5,000 sqft lab will expand Recipharm’s existing analytical capabilities and provide support for biotech and pharma customers
Manufacturing

BES completes $4.8m refurb for Recipharm

The 4000 sqm facility, located in King’s Lynn, has seen an extensive redesign and refurbishment
Subscribe now